studyId: syn53604892 studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment initiative: Other fundingAgency: Other
Drop files to upload
mqc_gatk-base-recalibrator-quality-scores-plot_Pre-recalibration_Percent.txt page is loading…